Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions

Clinical and Experimental Allergy

Volumn 28, Issue 11, 1998, Pages 1332-1339

  O'Sullivan, S ^a   Roquet, A ^b   Dahlen B ^b   Dahlen S E ^a   Kumlin, M ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

11 PGF2; Allergen induced bronchoconstriction; Early late asthmatic response; Eosinophil protein X; Leukotrienes; Mast cell; N( ) methylhistamine; Urinary 9

Indexed keywords

11 EPIPROSTAGLANDIN F2 ALPHA; ALLERGEN; IMMUNOGLOBULIN E; LEUKOTRIENE E4; MAJOR BASIC PROTEIN; TELE METHYLHISTAMINE;

ADULT; AIRWAY OBSTRUCTION; ALLERGIC ASTHMA; ARTICLE; BRONCHOSPASM; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; INHALATION TEST; MALE; MAST CELL; MEDIATOR RELEASE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RESPIRATORY TRACT INFLAMMATION; URINARY EXCRETION;

ADOLESCENT; ADULT; ALLERGENS; ASTHMA; BIOLOGICAL MARKERS; BLOOD PROTEINS; BRONCHIAL PROVOCATION TESTS; DINOPROST; EOSINOPHIL-DERIVED NEUROTOXIN; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INFLAMMATION MEDIATORS; LEUKOTRIENE E4; LUNG; MALE; METHYLHISTAMINES; RIBONUCLEASES; TIME FACTORS;

EID: 0031797328     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1998.00368.x     Document Type: Article

References (39)

1. Booij-Noord H, De Vries K, Sluiter HJ, Orie NGM. Late bronchial obstructive reaction to experimental inhalation of house dust extract. Clin Allergy 1972; 2:43-6.
2. Austen KF, Orange RP. Bronchial asthma: the possible role of chemical mediators of immediate hypersensitivity in the pathogenesis of subacute chronic disease. Am Rev Respir Dis 1975; 112:423-36.
3. Kaufmann HF, van der Heide S, de Monchy JGR, de Vries K. Plasma histamine concentrations and complement activation during house dust mite-provoked bronchial-obstructive reactions. Clin Allergy 1983; 13:219-28.
4. Wood-Baker R, Finnerty JP, Holgate ST. Plasma and urinary histamine in allergen-induced early and late phase asthmatic responses. Eur Respir J 1993; 6:1138-44.
5. τ-methylhistamine during early and late allergen-induced bronchial-obstructive reactions. J Allergy Clin Immunol 1984; 74:240-5.
6. 2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction. J Allergy Clin Immunol 1996; 98:421-32.
7. Dworski R, Fitzgerald GA, Oates JA, Sheller JR. Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med 1994; 149:953-9.
8. 2 in patients with systemic mastocytosis. N Engl J Med 1980; 180:1400-4.
9. Liu MC, Hubbard WC, Proud D et al. Immediate and Late Inflammatory Responses to Ragweed Antigen Challenge of the Peripheral Airways in Allergic Asthmatics. Am Rev Respir Dis 1991; 144:51-8.
10. Ind PW, Barnes PJ, Brown MJ, Causon R, Dollery CT. Measurement of plasma histamine in asthma. Clin Allergy 1983; 16:61-7.
11. Keyzer JJ, Wolthers BG, Muskiet FAJ et al. Measurement of plasma histamine by stable isotope dilution gas chromatography-mass spectrometry: methodology and normal values. Anal Biochem 1984; 139:474-81.
12. Durham SR, Loegering DA, Dunnette BS, Gleich GJ, Kay AB. Blood eosinophils and eosinphil-derived proteins in allergic asthma. J Allergy Clin Immunol 1989; 84:931-6.
13. DeMonchy JGR, Kauffman KF, Venge P et al. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985; 131:373-6.
14. Pin I, Freitag AP, O'Byrne PM. Changes in the cellular profile of induced sputum after allergen-induced asthmatic responses. Am Rev Respir Dis 1992; 145:1265-9.
15. Pedersen B, Dahl R, Larsen BB, Venge P. The effect of salmeterol on the early- and late-phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein X. Allergy 1993; 48:377-82.
16. Dahl R, Venge P, Olsson I. Variations of blood eosinophils and eosinophil cationic protein in serum in patients with bronchial asthma. Allergy 1978; 33:211-5.
17. 4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet 1989; 1:584-8.
18. 4 and histamine in asthmatics. Am Rev Respir Dis 1992; 146:96-103.
19. 4 in patients with asthma. Effect of airways reactivity and sodium cromoglycate. Am Rev Respir Dis 1991; 143:1322-8.
20. 4 antagonist, L-648.051. Allergy 1992; 47:599-603.
21. 4 levels during early and late asthmatic responses. J Allergy Clin Immunol 1990; 86:211-20.
22. Roquet A, Dahlén B, Kumlin M et al. Combined Antagonism of Leukotrienes and Histamine Produces Predominant Inhibition of Allergen-Induced Early and Late Phase Airway Obstruction in Asthmatics. Am J Respir Crit Care Med 1997; 155:1856-63.
23. Pradelles P, Grassi J, Maclouf J. Enzyme immunoassays of cicosanoids using acetylcholinesterase. Meth Enzymol 1990; 187:24-34.
24. Durham SR, Lee TH, Cromwell O et al. Immunological studies in allergen-induced late-phase asthmatic reactions. J Allergy Clin Immunol 1984; 74:49-60.
25. Hermann K, Hertenberger B, Ring J. Measurement and characterisation of histamine and Methylhistamine in human urine under histamine-rich and histamine poor diets. Int Arch Allergy Immunol 1993; 101:13-9.
26. 2 in vivo in humans following administration of nicotinic acid. Prostaglandins 1989; 38:263-74.
27. Naclerio RM, Hubbard W, Lichtenstein LM, Kagey-Sobotka A, Proud D. Origin of late phase histamine release. J Allergy Clin Immunol 1996; 98:721-3.
28. MacGlashan DW, Schleimer RP, Peters SP et al. Comparitive studies of human basophils and mast cells. Federation Proc 1983; 42:2504-9.
29. Tuylor IK, O'Shaughnessy KM, Fuller RW, Dollery CT. Effect of cysteinyl-leukotriene receptor antagonist ICI 204. 219 On Allergen-Induced Bronchoconstriction And Airway Hyperreactivity In Atopic Subjects. Lancet 1991; 337:690-4.
30. Diamant Z, Timmers MC, van der Veen H et al. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo. J Allergy Clin Immunol 1995; 1:42-51.
31. 2 in a normal human male volunteer. J Biol Chem 1985; 260:13172-80.
32. 4 by human individuals. Biochem Biophys Res Comm 1987; 148:864-8.
33. 4 into the vascular compartment in healthy subjects. Am J Physiol 1992; 263:H244-9.
34. τ-methyl histamine concentration in plasma and urine as a parameter for histamine release during anaphylactoid reactions. Agents Actions 1985; 16:76-9.
35. 14C-histamine given intra bronchially to asthmatic patients. Allergy 1980; 35:31-6.
36. Kristjánsson S, Stranngård I-L, Strannegård Ö et al. Urinary eosinophil protein X (EPX) in children with utopic asthma. A useful marker of anti-inflammatory treatment. J Allergy Clin Immunol 1996; 97 (6):1179-87.
37. Peterson C, Enander I, Lindgren D, Nordvall SL, Alving K. Measurement and characterisation of eosinophil protein X (EPX) in urine [abstract]. Am J Respir Crit Care Med 1996; 153:A201.
38. 4 in humans. Clin Exp Allergy 1995; 25:467-79.
39. Postma DS, Koëter GH, Keyzer JJ, Meurs H. Influence of slow-release terbutaline on the cireadian variation of catecholamines, histamine, and lung function in non-allergic patients with partly reversible airflow obstruction. J Allergy Clin Immunol 1986; 77:471-7.